share_log

ReShape Lifesciences Tweets 'Will #GLP1 Medications Replace #weightloss #surgery? According to ReShape CEO, Paul Hickey, via @InvestingCom, #GLP1s Are a Very Attractive Tool to Fight #obesity. However, Our ReShape Lap-Band Is Safe and Less Invasive'

ReShape Lifesciences Tweets 'Will #GLP1 Medications Replace #weightloss #surgery? According to ReShape CEO, Paul Hickey, via @InvestingCom, #GLP1s Are a Very Attractive Tool to Fight #obesity. However, Our ReShape Lap-Band Is Safe and Less Invasive'

ReShape Lifesciences 推文 “#GLP1 藥物會取代 #weightloss #surgery 嗎？根據reShape首席執行官保羅·希基通過 @InvestingCom 的說法，#GLP1s 是對抗 #obesity 的非常有吸引力的工具。但是，我們的 reShape Lap-Band 安全且侵入性較小'
Benzinga ·  04/04 01:39

ReShape Lifesciences Tweets 'Will #GLP1 Medications Replace #weightloss #surgery? According to ReShape CEO, Paul Hickey, via @InvestingCom, #GLP1s Are a Very Attractive Tool to Fight #obesity. However, Our ReShape Lap-Band Is Safe and Less Invasive'

ReShape Lifesciences 推文 “#GLP1 藥物會取代 #weightloss #surgery 嗎？根據reShape首席執行官保羅·希基通過 @InvestingCom 的說法，#GLP1s 是對抗 #obesity 的非常有吸引力的工具。但是，我們的 reShape Lap-Band 安全且侵入性較小'

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論